January 25, 2015 5:59 AM ET


Company Overview of Novartis Consumer Health, Inc.

Company Overview

Novartis Consumer Health, Inc. creates, develops, and manufactures products that restore, maintain, and improve the health and well-being. It offers various over-the-counter products, including mineral supplements, topical antifungal agents, systemic and topical analgesic, antacids, anti inflammatory pain relief gel, and antifungal products; and products for cold sore treatment, overnight laxative, skin irritation treatment, adult gas relief, smoking cessation, nasal decongestant, adult cold and flu, skin care, and pediatric cough and cold. The company also provides contact lenses and lens care products. In addition, it involves in the research, development, and commercialization of pet and ...

200 Kimball Drive

Parsippany, NJ 07054-0622

United States





Key Executives for Novartis Consumer Health, Inc.

Chief Executive Officer of Vaccines and Diagnostics
Age: 58
President of BioMedical Research
Age: 63
Corporate Secretary
Head of Corporate Communications
Head of Human Resources
Age: 62
Compensation as of Fiscal Year 2014.

Novartis Consumer Health, Inc. Key Developments

Novartis Consumer Health, Inc. Presents at EBD Group's 7th Annual BIO-Europe Spring Conference 2013, Mar-11-2013

Novartis Consumer Health, Inc. Presents at EBD Group's 7th Annual BIO-Europe Spring Conference 2013, Mar-11-2013 . Venue: Centre Covencions International Barcelona, Plaça de Willy Brandt, 11-14, 08019 Barcelona, Spain.

Novartis Consumer Health, Inc. Announces Voluntarily Recall of Select Lots of Triaminic(R) Syrups and Theraflu Warming Relief(R) Syrups Manufactured in the United States Before December 2011

Novartis Consumer Health, Inc. announced that it is voluntarily recalling certain lots of Triaminic(R) Syrups and Theraflu Warming Relief(R) Syrups that were manufactured in the United States before December 2011. The company has decided to issue a voluntary recall to consumers, retail customers and wholesalers in the US because the child-resistant feature of the bottle cap may not function properly, enabling the cap to be removed with the tamper-evident seal still in place. The company received four adverse events related to this issue on bottles of Triaminic(R) Syrups. There were no reports of adverse events related to this specific issue for Theraflu Warming Relief(R) Syrups. Triaminic(R) Syrups and Theraflu Warming Relief(R) Syrups continue to be safe and effective when used as directed on the package label. The products being recalled were produced at the Novartis Consumer Health manufacturing facility in Lincoln, Nebraska prior to the voluntary suspension of operations and shipments at the facility in December 2011. A consumer complaint in the US in late November 2012 triggered an internal investigation by Novartis Consumer Health that determined a voluntary recall was in the best interest of consumers.

Similar Private Companies By Industry

Company Name Region
RFI Extracts United States
Stonebridge Pharma LLC United States
La Belle, Inc. United States
FSC Laboratories, Inc. United States
Emmaus Medical, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Novartis Consumer Health, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.